Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.725 USD | +3.19% | +4.90% | -57.39% |
Apr. 26 | AbbVie raises annual profit forecast on strong Skyrizi sales | RE |
Apr. 12 | Revance Therapeutics, Inc. to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting | CI |